Liposomes: quo vadis?
- 1 April 1998
- journal article
- Published by Elsevier in Pharmaceutical Science & Technology Today
- Vol. 1 (1) , 19-31
- https://doi.org/10.1016/s1461-5347(98)00007-8
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Long Circulating Liposomes: Old Drugs, New TherapeuticsPublished by Springer Nature ,1998
- Opportunities in targeted drug delivery to Kupffer cells: delivery of immunomodulators to Kupffer cells-activation of tumoricidal propertiesAdvanced Drug Delivery Reviews, 1995
- Delivery of antimicrobials to infected tissue macrophagesAdvanced Drug Delivery Reviews, 1995
- Liposomes and ISCOMS as vaccine formulationsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Liposomal Vaccines: Clinical Status and Immunological Presentation for Humoral and Cellular ImmunityAnnals of the New York Academy of Sciences, 1995
- Modulation of Nonspecific Antimicrobial Resistance of Mice to Klebsiella Pneumoniae Septicemia by Liposome-Encapsulated Muramyl Tripeptide Phosphatidylethanolamine and Interferon-a Alone or CombinedThe Journal of Infectious Diseases, 1995
- Liposomal Presentation of Antigens for Human VaccinesPublished by Springer Nature ,1995
- Liposomes as Immunoadjuvants and Vaccine Carriers: Antigen EntrapmentImmunoMethods, 1994
- Systemic Targeting of Liposome-Encapsulated Immunomodulators to Macrophages for Treatment of Cancer MetastasisImmunoMethods, 1994
- Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.Journal of Clinical Investigation, 1992